Filing Details

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 2)*

Kamada Ltd.

---

 (Name of Issuer)

 

Ordinary Shares, Par Value NIS 1.00 Per Share

---

(Title of Class of Securities)

 

 M6240T109

(CUSIP Number)

---

---

(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)

 

---

(Date of Event which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ☐.

 

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be ”filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

*          The calculation is based on a total of 44,523,970 Ordinary Shares outstanding, as reported in the Annual Report on Form 20-F of Kamada Ltd., as filed with the Securities and Exchange Commission on February 26, 2020.    

CUSIP No. M6240T109

Page 6 of 10 Pages

 

---

The undersigned, FIMI 6 2016 Ltd. (“FIMI 6”), FIMI Opportunity 6, L.P. (“FIMI Opportunity”), FIMI Israel Opportunity 6, Limited Partnership (“FIMI Israel Opportunity”, and together with FIMI Opportunity, the “FIMI 6 Funds”), Or Adiv Ltd. (“Or Adiv”) and Ishay Davidi (together, the “Reporting Persons”) hereby file this Amendment No. 2 to Schedule 13D (the “Amendment”), which amends the Schedule 13D filed by the Reporting Persons on November 27, 2019, as amended by Amendment No. 1 to Schedule 13D filed by the Reporting Persons on January 21, 2020 (as amended, the “Schedule 13D”), with respect to the Ordinary Shares, par value NIS 1.00 per share (the “Ordinary Shares”), of Kamada Ltd., an Israeli company (“Kamada”).  The Amendment amends and supplements Items 3, 4 and 5 of the Schedule 13D.

Each of the Reporting Persons intends to continuously review its investment in Kamada, and may in the future determine, either alone or as part of a group (i) to acquire additional securities of Kamada, through open market purchases, private agreements or otherwise, (ii) to dispose of all or a portion of the securities of Kamada owned by it or (iii) to take any other available course of action, which could involve one or more of the types of transactions or have one or more of the results described in paragraphs (a) – (j) of Item 4 of Schedule 13D.  Notwithstanding anything contained herein, each of the Reporting Persons specifically reserves the right to change its intention with respect to any or all of such matters.

 

	By:	/s/ Ishay Davidi
		Name: Ishay Davidi
		Title: CEO
	FIMI Israel Opportunity 6, Limited Partnership By: FIMI 6 2016 Ltd., managing general partner

Page 10 of 10 Pages

---